Plant pigmentation
The presence of an ?animal-only? pigment, bilirubin, has been confirmed in the Bird of Paradise flower.
The presence of an “animal-only” pigment, bilirubin, has been confirmed in the Bird of Paradise flower. A study published in the American Society for Horticultural Science’s journal HortScience, has provided new insights into colour production in this iconic tropical plant.1
The Bird of Paradise plant, known for the distinctive shape of its orange and blue flowers, produces black seeds with vivid orange covering. The colour of this covering can remain unchanged for decades after the plant dies. This study used high performance liquid chromatography (HPLC) and HPLC–electrospray ionization–tandem mass spectrometry to show that the primary pigment of these arils was bilirubin, the yellowish hue normally associated with bruises and jaundice sufferers.
The study also tested to see whether the bright orange of the flowers was due to bilirubin. However, while its presence was detected in the vibrant sepals, the researchers concluded that the low concentrations made it unlikely that it contributed significantly to the colouring.
“This research is the first discovery of bilirubin in a flower,” said the researchers. “With further research on the function, distribution and synthesis of bilirubin in plants, the information may be useful for practical applications such as the manipulation of colour through breeding and genetics.”
1. C. Pirone et al., HortScience, 45(9), 1411–1415 (2010).
This story originally appeared in The Column. Click here to view that issue.
AI and GenAI Applications to Help Optimize Purification and Yield of Antibodies From Plasma
October 31st 2024Deriving antibodies from plasma products involves several steps, typically starting from the collection of plasma and ending with the purification of the desired antibodies. These are: plasma collection; plasma pooling; fractionation; antibody purification; concentration and formulation; quality control; and packaging and storage. This process results in a purified antibody product that can be used for therapeutic purposes, diagnostic tests, or research. Each step is critical to ensure the safety, efficacy, and quality of the final product. Applications of AI/GenAI in many of these steps can significantly help in the optimization of purification and yield of the desired antibodies. Some specific use-cases are: selecting and optimizing plasma units for optimized plasma pooling; GenAI solution for enterprise search on internal knowledge portal; analysing and optimizing production batch profitability, inventory, yields; monitoring production batch key performance indicators for outlier identification; monitoring production equipment to predict maintenance events; and reducing quality control laboratory testing turnaround time.
